Table 4. Odds ratios [95%CI] from cumulative odds models of adherence to guidelines (from 0: any adherence to 6: full adherence) between 2000 and 2006.
| 2003 | 2006 | ||||||||
| N | OR [95% CI] | N | OR [95% CI] | ||||||
| 6 vs others | 3,4,5,6 vs others | 1,2,3,4,5,6 vs 0 | 6 vs others | 3,4,5,6 vs others | 1,2,3,4,5,6 vs 0 | ||||
| A10 duration a , y | 14659 | 1.10 [0.94−1.29] | 1.02 [1.01−1.04] | 0.99 [0.97−1.00] | 16602 | 0.99 [0.99−1.00] | 1.09 [1.03−1.15] | 1.04 [1.03−1.05] | |
| Age, y | 14659 | 1.01 [0.98−1.05] | 0.99 [0.99−0.99] | 0.98 [0.98−0.98] | 16602 | 1.02 [1.02−1.03] | 0.99 [0.98−1.01] | 0.99 [0.99−0.99] | |
| TP visitsb | 14659 | 1.02 [1.00−1.03] | 1.03 [1.02−1.03] | 1.03 [1.03−1.04] | 16602 | 1.03 [1.02−1.04] | 1.03 [1.02−1.04] | 1.02 [1.02−1.02] | |
| Sex | Female | 7049 | 1 | 1 | 1 | 7718 | 1 | 1 | 1 |
| Male | 7610 | 0.59 [0.26−1.37] | 0.77 [0.71−0.84] | 0.85 [0.78−0.92] | 8884 | 0.87 [0.83−0.92] | 0.87 [0.83−0.92] | 0.87 [0.83−0.92] | |
| TP | D c | 1230 | 1 | 1 | 1 | 1422 | 1 | 1 | 1 |
| I-D c | 3416 | 0.18 [0.07−0.46] | 0.61 [0.53−0.70] | 0.83 [0.68−1.02] | 4100 | 0.75 [0.42−1.32] | 0.61 [0.53−0.69] | 0.72 [0.59−0.89] | |
| G-ID c | 9314 | 0.07 [0.03−0.19] | 0.40 [0.35−0.46] | 0.49 [0.41−0.60] | 10423 | 0.36 [0.20−0.65] | 0.47 [0.42−0.53] | 0.50 [0.41−0.60] | |
| O-GID c | 699 | 0.12 [0.01−1.18] | 0.42 [0.34−0.53] | 0.71 [0.54−0.93] | 657 | 0.18 [0.03−1.10] | 0.40 [0.32−0.49] | 0.42 [0.32−0.55] | |
| Living region | Luxembourg | 10719 | 1 | 1 | 1 | 12169 | 1 | 1 | 1 |
| Grevenmacher | 1677 | 1.51 [1.38−1.66] | 1.51 [1.38−1.66] | 1.51 [1.38−1.66] | 1891 | 1.65 [0.96−2.85] | 1.89 [1.71−2.09] | 1.62 [1.40−1.88] | |
| Diekirch | 2263 | 1.22 [1.13−1.33] | 1.22 [1.13−1.33] | 1.22 [1.13−1.33] | 2542 | 1.39 [0.80−2.40] | 1.23 [1.12−1.35] | 1.21 [1.07−1.36] | |
| Nationality | Luxembourg | 11053 | 1 | 1 | 1 | 12094 | 1 | 1 | 1 |
| EU-15 and EFTA d | 3189 | 0.75 [0.26−2.18] | 0.94 [0.86−1.04] | 0.95 [0.86−1.06] | 3971 | 0.65 [0.37−1.13] | 0.99 [0.92−1.07] | 0.94 [0.85−1.04] | |
| Other | 417 | 0.40 [0.01−23.62] | 0.72 [0.56−0.94] | 0.61 [0.49−0.76] | 537 | 0.41 [0.07−2.44] | 0.64 [0.52−0.78] | 0.54 [0.44−0.67] | |
| A10 treatment | Insulin only | 1484 | 1 | 1 | 1 | 1658 | 1 | 1 | 1 |
| Oral only | 11727 | 1.41 [1.27−1.56] | 1.41 [1.27−1.56] | 1.41 [1.27−1.56] | 13142 | 1.48 [1.35−1.63] | 1.48 [1.35−1.63] | 1.48 [1.35−1.63] | |
| Mixed | 1448 | 1.35 [1.19−1.54] | 1.35 [1.19−1.54] | 1.35 [1.19−1.54] | 1802 | 1.35 [1.20−1.52] | 1.35 [1.20−1.52] | 1.35 [1.20−1.52] | |
| Hospitalization | None | 4215 | 1 | 1 | 1 | 5426 | 1 | 1 | 1 |
| (n = year) | n-2 or earlier | 0 | NA | NA | NA | 6062 | 1.19 [1.12−1.28] | 1.19 [1.12−1.28] | 1.19 [1.12−1.28] |
| n-1 or n | 4168 | 2.09 [0.53−8.23] | 1.29 [1.15−1.45] | 1.08 [0.96−1.21] | 5114 | 1.34 [1.24−1.45] | 1.34 [1.24−1.45] | 1.34 [1.24−1.45] | |
| n+1 or later | 6276 | 1.65 [0.41−6.70] | 1.32 [1.19−1.47] | 1.66 [1.50−1.83] | 0 | NA | NA | NA | |
a
A10 treatment duration; b Number of visits to the Treating Physician (TP); c D: At least a diabetologist; I-D: At least an internist but no diabetologist; G-ID: At least a GP but no diabetologist, nor internist; O-GID: A physician but no GP, nor diabetologist, nor internist; d European Union 15 countries (except Luxembourg) and European Free Trade Association countries; NA: Not available.